Amal M. Johnson - 26 Jan 2024 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
Director
Signature
By: Donna Spinola For: Johnson, Amal M.
Issuer symbol
ISRG
Transactions as of
26 Jan 2024
Net transactions value
-$2,096,532
Form type
4
Filing time
29 Jan 2024, 17:25:47 UTC
Previous filing
17 Nov 2023
Next filing
26 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $381,501 +6,696 +57% $56.97 18,402 26 Jan 2024 Direct F1
transaction ISRG Common Stock Sale $2,478,032 -6,696 -36% $370.08 11,706 26 Jan 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -6,696 -100% $0.000000* 0 26 Jan 2024 Common Stock 6,696 $56.97 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 1, 2024.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $368.45 to $371.65 as follows: 1,967 shares sold at $368.45 to $369.45; 2,838 shares sold at $369.54 to $370.52; and 1,891 shares sold at $370.65 to $371.65. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company.